What is tarsal (meibomian) conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tarsal conjunctivitis is an inflammatory condition affecting the tarsal conjunctiva, characterized by inflammation, redness, and the formation of small bumps called papillae on the underside of the eyelids, commonly occurring as a reaction to allergens, contact lens wear, or as part of more extensive allergic eye diseases. This condition is also known as meibomian conjunctivitis, and it is essential to differentiate it from other types of conjunctivitis, such as rosacea conjunctivitis, contact lens–related keratoconjunctivitis, or giant papillary conjunctivitis (GPC) 1. The symptoms of tarsal conjunctivitis typically include eye redness, itching, tearing, mucous discharge, and a gritty sensation.

Causes and Risk Factors

The causes of tarsal conjunctivitis can be diverse, including:

  • Allergens
  • Contact lens wear
  • Mechanical irritation
  • Systemic conditions such as atopy or acute infections
  • Ocular diseases like dry eye or blepharitis 1.

Treatment and Management

Treatment depends on the underlying cause but often includes:

  • Artificial tears for lubrication
  • Antihistamine eye drops like ketotifen or olopatadine for allergic cases
  • Topical steroids like fluorometholone 0.1% for more severe inflammation
  • Cold compresses for symptomatic relief
  • Changing lens type, reducing wearing time, or improving lens cleaning regimens if contact lens wear is the cause 1.

Pathophysiology

The condition develops because allergens or mechanical irritation trigger mast cell degranulation and release of inflammatory mediators in the conjunctival tissue, leading to the characteristic papillary reaction on the tarsal surface. It is crucial to address the underlying cause of the condition to prevent complications such as tarsal scarring, ptosis, or corneal abrasion/erosions 1.

Key Considerations

In clinical practice, it is essential to consider the potential sequelae of tarsal conjunctivitis, such as evaporative dry eye, corneal neovascularization, or stromal scarring, and to manage the condition accordingly to prevent these complications 1.

From the Research

Definition and Causes of Tarsal (Meibomian) Conjunctivitis

  • Tarsal conjunctivitis is a form of conjunctivitis that affects the tarsal conjunctiva, which is the membrane covering the inside of the eyelids 2.
  • It can be caused by various factors, including allergic reactions, toxic substances, and infections 2, 3.
  • The condition is characterized by inflammation of the tarsal conjunctiva, which can lead to symptoms such as epiphora, stickiness, and mild bulbar conjunctival hyperaemia 2.

Clinical Features and Diagnosis

  • The clinical features of tarsal conjunctivitis include bilateral moderate to severe upper and lower tarsal conjunctival papillary reaction, without corneal or eyelid changes 2.
  • Diagnosis is based on clinical history, eye evaluation, and laboratory tests such as allergological tests and conjunctival scraping 4, 3.
  • Histological examination of biopsies can also help confirm the diagnosis, showing a variable superficial stromal lymphocytic infiltrate and follicle formation 2.

Treatment and Management

  • Treatment of tarsal conjunctivitis depends on the underlying cause and severity of symptoms 4, 3.
  • Topical steroid drops can provide relief from symptoms, but withdrawal of the inciting agent is necessary to resolve the condition 2.
  • Avoidance of potential contact allergens is also crucial in managing the condition 2.
  • In severe cases, novel steroid-sparing therapies such as Cyclosporine A eye drops or topical Tacrolimus may be used 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chronic tarsal conjunctivitis.

BMC ophthalmology, 2016

Research

Allergic conjunctivitis: current concepts on pathogenesis and management.

Journal of biological regulators and homeostatic agents, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.